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Abstract
Background Patients with ocular toxoplasmosis (OT) de-
velop autoreactivity to several retinal antigens, including
retinal S-antigen. By establishing an experimental rabbit
model of systemic and of primary and secondary ocular
toxoplasmosis, we wished to investigate the onset and
development of humoral response to retinal S-antigen.
Methods Of twelve infection-naïve rabbits, six were left
untreated, and the other six were infected subcutaneously
with 5,000 tachyzoites of the highly virulent, non-cyst-
forming BK-strain of Toxoplasma gondii. Three months
later, the left eye of each animal was infected transvitreally
with 5,000 tachyzoites of the same strain. The right eye of
each rabbit served as an uninfected control. Blood and
aqueous humor were collected prior to infection, and up to
90 days thereafter. Using the ELISA technique, all samples
were analyzed in parallel for total IgG, and antibodies
against toxoplasmic, bovine retinal S-antigen and peptide
35 from human S-antigen.
Results In infection-naïve rabbits Toxoplasma-specific anti-
bodies were detected 10 to15 days after systemic and ocular
infection. Serum antibodies against retinal S-antigen and
peptide 35 were not detected in response to systemic
Toxoplasma infection. After ocular challenge, aqueous-
humour levels of antibodies against retinal S-antigen and
peptide 35 in the infected eye began to rise 10 to 15 days
later in infection-naïve, but not in infection-immunized
animals. During the early post-infection period, the con-
centrations of anti-retinal antibodies in the infected eye
correlated with the severity of inflammatory tissue destruc-
tion, but returned to baseline later even though the
inflammatory response persisted. In the uninfected partner
eye, concentrations of anti-retinal and toxoplasmic anti-
bodies did not correlate with each other.
Conclusion Our data afford no evidence of similarities
between toxoplasmic and retinal antigens, nor of infection-
induced humoral autoimmunity. They indicate rather that
retinal autoantigens are liberated in the context of inflam-
matory tissue destruction due to ocular toxoplasmosis.
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Introduction
Patients with ocular toxoplasmosis (OT) are known to
develop autoreactivity to retinal antigens, such as the S-
type. However, the contribution of this antibody production
to the OT pathology is not clear [1–7]. That autoimmune
processes do indeed play a pathophysiological role in OT is
evidenced by the greater prevalence of anti-Toxoplasma
gondii antibodies in patients with non-toxoplasmic endog-
enous uveitis than in healthy individuals [8]. On the other
hand, autoimmunity against retinal antigens can develop
also in patients with retinal detachment and diabetic
retinopathy, as well as in those with autoimmune diseases
in which the eye is not involved [9]. Cells that have been
derived from patients with Fuchs’ anterior uveitis without
evident retinal disease present a positive cellular response
to the retinal S-antigen compared to healthy controls [10].
According to current opinion, OT may be capable of
inducing autoimmunity in the context of an infection-
associated immunopathological process [11]. The autoim-
mune disease could be precipitated by at least one of three
basic influences, namely by genetic [12], environmental
[13–16] or immunoregulatory factors [17–19].
The immunopathological response could evolve at either
a cellular [1, 2, 20] or an humoral antigen-driven level [3, 4,
6]. In a murine model of OT, the destruction of retinal
tissue is effected mainly by an infiltration of mononuclear
cells [21]. Whether autoimmune phenomena are involved
also in the development of recurrences is still unclear [22].
In experimental toxoplasmic encephalitis, chronic disease is
associated with a maturation and prolonged activity of
dendritic cells [23, 24], which could thus well be involved
in its recurrences.
An infectious agent may predispose an individual to, or
actually precipitate autoimmune reactions by unmasking
sequestered autoantigens against cells that have been induced
to express class-II HLA antigens in response to the
underlying infection. On the other hand, the parasite may
be comprised of proteins that share an antigenic similarity
with human retinal antigens, thereby rendering it capable of
inducing an autoimmune reaction against ocular proteins, as
is the case in herpetic keratitis [25–27]. The disruption of the
ocular vascular barrier that follows the infectious and
inflammatory destruction of ocular tissue may propagate
the accumulation and binding of anti-retinal autoantibodies,
and exacerbate the destruction of tissue [7]. Interestingly,
naturally-occurring anti-retinal antibodies have been detected
in healthy individuals who have no history of ocular disease
[7, 28, 29]. Autoimmune reactivity in OT could represent an
unspecific epiphenomenon of retinal damage, in conjunction
with a secondary, parasite-induced release of antigens.
By drawing on an experimental rabbit model of systemic
and primary and secondary ocular toxoplasmosis [30], we
wished to investigate the onset and development of the
humoral response to the retinal S-antigen, using an
established autoantibody ELISA technique [31–33]. A
comparison between primary ocular and systemic toxoplas-
mosis will reveal whether any cross-reactivity exists
between toxoplasmal and retinal antigens, and that between
primary and secondary OT will disclose whether a
correlation exists between the levels of anti-retinal anti-
bodies and the degree of ocular tissue destruction.
Materials and methods
Protocol of rabbit infection with virulent BK strain
of Toxoplasma gondii tachyzoites
All animal experiments were approved by the local and
institutional Animal Ethics Committee, and were performed
in accordance with ARVO’s Guidelines for Animal Re-
search under the surveillance of the local Public Veterinary
Health authorities. Experimental ocular toxoplasmosis was
induced either as a primary disease in infection-naïve
rabbits or as a secondary one in infection-immunized
animals by the intraocular injection of tachyzoites of the
highly virulent BK strain of Toxoplasma gondii, as
previously described [30]. Twelve 4-month-old seronega-
tive Dutch belt rabbits of both sexes, weighing 3.5 to 5 kg,
were used in this study. They were obtained from a local
breeder and housed in an animal-keeping unit at the
University of Bern. Six of the rabbits were left untreated
until the time of ocular infection. Each of the other six
rabbits was infected subcutaneously with 5,000 tachyzoites
of the virulent, non-cyst-forming BK-strain of Toxoplasma
gondii. Between 8 and 28 days later, they were injected
intramuscularly with clindamycin (20 mg/kg of body
weight/day) to prevent a lethal course of events. Neverthe-
less, two of the six rabbits died. A 3-month period was then
allowed for the infection to quieten down. At the end of this
period, the left and the right eyes of the rabbits in each
group were fundoscopically examined after pupillary
dilatation to exclude the presence of any ocular pathology.
The left eye of the four infection-immunized and of the six
infection-naïve rabbits was then infected transvitreally with
5,000 tachyzoites of the BK-strain of Toxoplasma gondii
under indirect ophthalmoscopic control. The right eye of
each rabbit served as an uninfected control. Between 8 and
28 days later, all animals were intramuscularly injected with
clindamycin (to prevent a lethal course of events). The
rabbits were examined regularly. Samples of blood from the
ear vein and of aqueous humor from both eyes were
collected under conditions of general anaesthesia, both
prior to systemic or ocular infection (day “0”), and on days
5, 10, 15, 21, 28, 35, 42, 60, 72 and 90. All samples were
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processed immediately as described below. They were then
stored at −20°C until required for the antibody analyses,
which were run in parallel.
Methods
Collection and preparation of samples 150- to 250-µl
aliquots of aqueous humor were collected by puncturing
the anterior chamber with a 30-gauge needle, which was
connected to a tuberculin syringe. Each sample was
centrifuged immediately after its collection. The sediment
was used for the amplification of DNA (data not presented)
and the supernatant for the antibody analysis. Samples of
blood were withdrawn from the ear vein. They were clotted
and centrifuged to yield the serum, which was also used for
the antibody analysis.
Total rabbit IgG This was quantified using the ELISA
technique. A triplicate set of controls with a known antibody
concentration was run in parallel with the test samples on
each test plate to internally equilibrate the system. The test
samples were run in duplicate, and the average measurement
was used for subsequent calculations. As outlined in a
previous study report [34], we attempted to quantify not only
IgG but also IgM and IgA, but none of these were
sufficiently specific to permit their unique determination
without binding to rabbit IgG, so running the corresponding
analyses was judged not useful.
Anti-Toxoplasma rabbit IgG This was also quantified using
the ELISA technique. For this purpose, tachyzoites of
Toxoplasma gondii that had been killed by freezing and
thawing were employed, as previously described [34]. To
detect the local production of antibodies, the cut-off level
for the Goldmann–Witmer coefficient (antibody ratio C)
was arbitrarily set at C≥3.
The level of antibodies against the retinal S-antigen and
peptide 35 were similarly quantified using the enzyme-
linked immunosorbent assay (ELISA) technique [32, 33].
Since peptide 35 is a major epitope in the S-Ag molecule,
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Fig. 1 Concentrations of total
IgG in the serum and aqueous
humour of rabbits that had been
infected with 5000 tachyzoites
of the BK strain of
Toxoplasma gondii. a Primary
systemic toxoplasmosis.
b Primary OT. c Secondary OT
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and since there is a sequence homology between peptide 35
from rabbit, rat and human, we checked the antibody
response to both, the entire bovine S-Ag molecule and to
peptide 35 in toxoplasmic rabbits.
Briefly, microtiter 96-well plates (Nunc-immuno plate,
Roskilde, Denmark) were coated with retinal S-antigen
(2 μg/ml) and peptide 35 (2 μg/ml; 35). Serum and aqueous
humor samples of each rabbit were added to the wells at
dilution 1/50. Serial dilutions between I/20 to 1/1000, of rat
sera with high antibody titers to S-Ag followed by
incubation with horseradish peroxidase-conjugated goat
anti-rat IgG (H + L), and of randomly selected test rabbit
sera and aqueous humor samples, were included in each
assay to validate the sensitivity and the variation of the
ELISA. The dilution 1/50 was chosen since no background
was detected at this dilution. Since we had to titrate
numerous samples of blood and aqueous humors, and to
avoid variations between the plates, we incubated the plates
coated with dilutions of samples overnight and processed
for antibody titration all the plates at the same time the day
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Fig. 2 Concentrations of anti-
Toxoplasma-specific IgG in
the serum and aqueous humour
of rabbits that had been infected
with 5000 tachyzoites of the BK
strain of Toxoplasma gondii.
a Primary systemic toxoplasmo-
sis. b Primary OT. c Secondary
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after. Results were not different for samples which had been
incubated for 2 hours or overnight. After incubation overnight
at 4°C to allow antibody to bind antigen, the samples were
removed and the wells were washed. Bound antibody was
detected with horseradish peroxidase-conjugated goat anti-
rabbit IgG (H + L; 1/1000 diluted) (Zymed Laboratories, San
Francisco, CA, USA) and application of O-phenylenediamine
substrate in 0.1 M citrate buffer (Sigma, L’Isle D’Abeau 219
Chesnes, France). Absorbance was read at 490 nm, and mean
optical density (OD) ± SD was calculated for each group.
Data are represented as median, minimal and maximal values,
together with the standard deviation. For the statistical
analysis (Student’s t-test), the data were assumed to be
normally distributed. Since the number of samples was
limited, the level for statistical significance was set at p<0.01.
Results
Despite prophylactic treatment with clindamycin, only eight
out of 12 rabbits (four of the six with primary systemic
toxoplasmosis and four of the six with primary ocular
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of rabbits that had been infected
with 5000 tachyzoiotes of the
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a Primary systemic toxoplasmo-
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Graefes Arch Clin Exp Ophthalmol (2010) 248:573–584 577
toxoplasmosis (OT) survived the infection with Toxoplasma
until day 90. Hence, the group of animals with secondary
OT consisted of four rabbits.
In Figs. 1, 2, 3 and 4, temporal changes in the
concentrations of total IgG (Fig. 1), of Toxoplasma-specific
IgG (Fig. 2), of retinal S-antigen-specific IgG (Fig. 3) and of
retinal p35-antigen-specific IgG (Fig. 4) are depicted for the
rabbits with primary systemic toxoplasmosis (Figs. 1a, 2a, 3a
and 4a), with primary OT (Figs. 1b, 2b, 3b and 4b), and
with secondary OT (Figs. 1c, 2c, 3c and 4c). These sets of
data were used to calculate the antibody coefficients for
Toxoplama-specific IgG (Fig. 5), for retinal S-antigen-
specific IgG (Fig. 6) and for retinal p35-antigen-specific IgG
(Fig. 7) in each disease category: primary systemic toxoplas-
mosis (Figs. 5a, 6a and 7a), primary OT (Figs. 5b, 6b and 7b)
and secondary OT (Figs. 5c, 6c and 7c).
The systemic injection of rabbits with Toxoplasma
elicited a twofold increase of levels of total IgG in the
serum and aqueous humor (Fig. 1a).
This rise indicates that a humoral immune response had
been stimulated. Ocular infection with Toxoplasma elicited
an increase in the local level of total IgG (Fig. 1b and c),
which may reflect the stimulation of a local humoral
immune response and/or a breakdown of the blood ocular
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Fig. 4 Concentrations of anti-
retinal p35-antigen-specific IgG
in the serum and aqueous hu-
mour of rabbits that had been
infected with 5000 tachyzoiotes
of the BK strain of Toxoplasma
gondii. a Primary systemic
toxoplasmosis. b Primary OT.
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barrier. The time-lapse that was required for the production
of antibodies was 10 to 15 days (Fig. 2b and c), which is
consistent with previously published data [33]. In infection-
immunized animals, intravitreal reinfection with Toxoplasma
did not induce any change in the serum antibody levels,
which is in accordance with the situation in humans.
However, in the infected eye, the local level of Toxoplasma-
specific IgG increased (Fig. 2c).
Infection with Toxoplasma did not elicit any change in
the serum levels of antibodies against the retinal S-antigen
and peptide 35. Looking at individual response, there is a
delayed increase of serum levels of anti-S-Ag. Presence of
low concentrations of specific IgG to S-antigen and peptide
35 is constitutively detected in the serum at day 0 in all
groups of rabbits, but not in the aqueous humor when the
blood–ocular barrier is intact. The local levels of antibodies
against the retinal antigens increased after 10 to 15 days in
an interindividually highly variable fashion in the infected
eye of the infection-naïve, but not (or to a lesser extent),
again in an interindividually highly variable fashion, in that
of infection-immunized rabbits (Figs. 3 and 4). A local
synthesis of anti-retinal antibodies has to be anticipated,
since an elevation of specific IgG to S-antigen and peptide
35 in aqueous humor was found in the infected eye of the
infection-naïve and infection-immunized rabbits, whereas
no such antibodies were detected in the uninfected eye.
The antibody coefficient C for Toxoplasma in the
infected eye reached levels above 2 after 15 to 42 days in
rabbits with primary OT, and after 28 to 48 days in those
with secondary OT. These levels were never reached in any
of the animals with systemic toxoplasmosis (Fig. 5). An
antibody coefficient of 3 or more was never consistently
achieved in any of the animals, which is in accordance with
previously published data [34].
In animals with systemic toxoplasmosis, the antibody
coefficients in the infected eye for the retinal S-antigen and
for peptide 35 rose non-significantly from day 42 after the
systemic infection. In animals with primary or secondary
OT, the antibody coefficients in the infected eye tended to
drop during the early post-infection phase and then to
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recover (Figs. 6 and 7), but were always lower than in the
non-infected eye. This may either reflect a wash-out of
these antibodies in consequence of the blood–ocular barrier
breakdown or a binding of antibodies to (liberated as well
as tissue-bound) local retinal antigens. Interestingly, the
antibody coefficient for anti-retinal antibodies was more
than 10-fold higher than those for the Toxoplasma-specific
antibodies. However, owing to the high standard deviations,
the differences were not consistently significant (p<0.01)
The rabbits used in this study were not congenic, which
may explain the inconstistancy of the results between
individual rabbits (Fig. 8a and b show this exemplarily for
the group of primary ocular toxoplasmosis). These results
suggest either that the humoral immune response against
retinal antigens is a more localized phenomenon than that
against toxoplasmal antigens, or that the response to
Toxoplasma infection is not a strictly compartmentalized
event, even after ocular challenge.
Discussion
Using an experimental rabbit model of systemic and ocular
toxoplasmosis [33], and an established autoantibody ELISA
technique [32, 33], we demonstrated that the concentrations
of anti-retinal antibodies increased in the infected eyes
during the early post-infection period. The data correlated
with the degree of infectious tissue destruction at the
clinical level (data not presented). In the uninfected partner
eyes, the concentrations of anti-retinal antibodies did not
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rise, and no tissue destruction was observed. The fact that
the partner eye did not respond with antiretinal antibody
production strongly argues against an infection-induced
autoimmune response to retinal antigens. Hence, this would
be expected to evolve bilaterally. Instead, the antibodies
may have been induced locally in response to the retinal
lesioning. The concentrations of anti-retinal antibodies
failed to increase after the systemic infection of rabbits
with Toxoplasma. This finding indicates that the causes for
retinal and toxoplasmic antigen synthesis are distinct. In
rabbits with either primary or secondary OT, the levels of
the anti-retinal antibodies were restored to baseline levels
during the later post-infection period, even though the
inflammatory infiltration of the anterior chamber, of the
vitreous and of the intraocular tissues persisted. Moreover,
the clinically observed degree of tissue destruction did not
parallel the levels of anti-Toxoplasma antibodies. Hence,
our data offer no support for the existence of an infection-
induced humoral autoimmune response that is based upon a
cross-reactivity between toxoplasmic and retinal antigens
[6]. They suggest rather that retinal autoantigens are
liberated in the context of inflammatory tissue destruction
[20]. On the other hand, in mice that have been infected with
Toxoplasma gondii in utero, retinal vasculitis develops, as
well as the almost uniform and highly-selective destruction
of the photoreceptor layer. These share features in common
with experimental autoimmune retinitis [36, 37].
The precise pathogenic role of retinal autoimmune
responses in eye disease is unknown [38]. The humoral
autoimmune response may be no more than an epiphenom-
enon which develops after damage to the retina by either
physical agencies, micro-organisms, or immunological
impairment [39, 40]. And even if autoimmunity does not
itself initiate ocular inflammation, it might perpetuate and
sustain the inflammatory state, and thereby exacerbate the
tissue damage [9]. In our study, the quantitative disparity
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and the temporal asynchrony in the evolution of anti-retinal
and anti-Toxoplasma antibodies suggest that humoral
autoimmunity might well develop as an epiphenomenon
in the context of inflammatory tissue destruction [19].
However, the levels of autoantibodies that are produced in
consequence of the infectious tissue destruction may not be
sufficient to yield evidence of permanent parasite-induced
autoreactivity [6, 38].
Our data do not permit the drawing of any conclusions
relating to autoimmunity at the cellular level and the
interrelation between cellular and humoral immune response
[41]. Interestingly, it has been reported that in the eyes of
horses with equine recurrent uveitis, both IgG antibodies and
autoreactive T-cells specific for retinal antigens were
detected [42]. The role of infectious agents at the origin of
the autoimmune response to retinal autoantigens has
remained less clear [42]. In addition, the analysis of certain
serum markers during equine recurrent uveitis has shown
that serum is a valuable tool for analysing the onset and
possible recurrences of the disease [43].
T-cells that have been derived from the peripheral blood
of patients with mild OT react more strongly to retinal
autoantigens than do those that have been derived from
individuals with a more aggressive form of the disease [6,
38]. Exogenous, non-self antigens can stimulate type-2 T-
helper cells, and thereby modify the cytokine environment
sufficiently to alter the cytokine phenotype of inflammatory,
autoreactive T-cell clones [41, 44]. This response may afford
the host some protection against experimental autoimmune
encephalitis and possibly other T-cell-mediated autoimmune
diseases. Hence, infection with Toxoplasma could even
protect the host against the development of overt autoim-
mune diseases at immuno-privileged sites such as the eye
and the brain [44]. Outside the retina, anti-retinal antigens
could help in the development of peripheral tolerance, as
well as in protecting the host against autoimmunity [45]. The
result may be the consequence of conflicting cellular
immune responses [46]. In OT, as in more overt autoimmune
diseases, the cellular immune response is mediated by type-1
T-helper cells. Consequently, the cytokine profiles may be
similar in each case, but tailored to suit the pathogenic agency
[46, 47]. Such tailoring might explain why the autoimmune
response is lower in OT than in autoimmune diseases [48].
Our own study suffered from two major drawbacks.
Firstly, some interesting information may have been lost due
to the smallness of the animal cohort, which precluded a
rigorous statistical evaluation of the data. Secondly, the
generally poor specificity of anti-rabbit antibodies precluded
a quantification of specific IgM, IgA and IgE antibodies. A
hypersensitivity reaction to Toxoplasma antigens or an
autoimmune response against retinal autoantigens could
conceivably contribute to the clinical disease [2, 49, 50],
although IgE antibodies are not usually detected [51]. In OT,
the degree of anti-retinal reactivity correlates not only with
the concentrations of antibodies against the retinal S-antigen,
but also with those of antibodies against the interphotor-
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Fig. 8 Concentrations of anti-
retinal S-antigen-specific (a) and
anti-p35.specific (b) IgG in the
aqueous humour and serum of
single rabbits (PO1–PO6) that
had primarily been infected in
the left eye with 5,000 tachy-
zoites of the BK strain of
Toxoplasma gondii
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eceptor binding protein [52] and other retinal antigens [39,
40]. Interestingly, the antibody coefficients for retinal
autoantigens were consistently more than 10-fold higher
than those for toxoplasmic antigens. This finding reconfirms
the assumption that the local production of an antibody
parallels the strictly local availability of the corresponding
antigen. Moreover, the antibody coefficients tended to be
lower in the infected than in the uninfected eye. This finding
may be accounted for by a breakdown of the uveovascular
barrier and the ensuing dispersal of the antibodies.
In conclusion, our data indicate that at the humoral level,
infection-induced immunopathological rather than autoim-
mune phenomena contribute to the inflammatory response
in OT, and that the latter do not influence the clinical
evolution of the disease.
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